[Current therapeutic indications of thalidomide and lenalidomide]
- PMID: 23830554
- DOI: 10.1016/j.medcli.2013.04.038
[Current therapeutic indications of thalidomide and lenalidomide]
Abstract
Thalidomide is a synthetic glutamic acid derivative first introduced in 1956 in Germany as an over the counter medications. It was thought to be one of the safest sedatives ever produced as it was effective in small doses, was not addictive, and did not have acute side-effects such as motor impairment, but was quickly removed from market after it was linked to cases of severe birth defects. The Food and Drug Administration approved use in the treatment of erythema nodosum leprosum. Further, it was shown its effectiveness in unresponsive dermatological conditions such as actinic prurigo, adult Langerhans cell hystiocytosis, aphthous stomatitis, Behçet syndrome, graft-versus-host disease, cutaneous sarcoidosis, erythema multiforme, Jessner-Kanof lymphocytic infiltration of the skin, Kaposi sarcoma, lichen planus, lupus erythematosus, melanoma, prurigo nodularis, pyoderma gangrenosum and others. In May 2006, it was approved for the treating multiple myeloma. New thalidomide analogues have been developed but lack clinical experience. This paper is a review of the history, pharmacology, mechanism of action, clinical applications and side effects of thalidomide and its analogues.
Keywords: Lenalidomida; Lenalidomide; Talidomida; Terapeutica; Thalidomide; Therapeutic.
Copyright © 2013 Elsevier España, S.L. All rights reserved.
Similar articles
-
Thalidomide: dermatological indications, mechanisms of action and side-effects.Br J Dermatol. 2005 Aug;153(2):254-73. doi: 10.1111/j.1365-2133.2005.06747.x. Br J Dermatol. 2005. PMID: 16086735 Review.
-
Innovative uses of thalidomide.Dermatol Clin. 2010 Jul;28(3):577-86. doi: 10.1016/j.det.2010.03.003. Dermatol Clin. 2010. PMID: 20510766 Review.
-
Review of thalidomide use in the pediatric population.J Am Acad Dermatol. 2015 Apr;72(4):703-11. doi: 10.1016/j.jaad.2015.01.002. Epub 2015 Jan 21. J Am Acad Dermatol. 2015. PMID: 25617013 Review.
-
A review of thalidomide's history and current dermatological applications.Dermatol Online J. 2003 Aug;9(3):5. Dermatol Online J. 2003. PMID: 12952752 Review.
-
Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.J Am Acad Dermatol. 1996 Dec;35(6):969-79. doi: 10.1016/s0190-9622(96)90122-x. J Am Acad Dermatol. 1996. PMID: 8959957 Review.
Cited by
-
Lenalidomide: An Alternative Treatment for Refractory Behçet's Disease and Relapsing Polychondritis.Eur J Case Rep Intern Med. 2019 May 31;6(6):001117. doi: 10.12890/2019_001117. eCollection 2019. Eur J Case Rep Intern Med. 2019. PMID: 31293992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases